Medicare to Cover Wegovy for Patients With Serious Heart Risks

The cost of Wegovy will soon be covered by Medicare, according to an announcement from the federal health insurance program for seniors on Thursday. And while that’s great news for people over 65 who want access to a medication that’s drawn so much attention for its ability to help with weight loss, there’s just one … Read more

Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

The logo of Danish pharmaceutical company is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February 1, 2017. Liselotte Sabroe | AFP | Getty Images Wegovy obesity drug maker Novo Nordisk surpassed Tesla in market value, after fresh early trial data showed positive results for its new experimental weight loss pill. Shares … Read more

Nvidia rally fueling FOMO in overall market: Evercore’s Julian Emanuel

Evercore ISI’s Julian Emanuel thinks Nvidia’s monster rally is fueling a fear of missing out in the market. He finds clients, including many who traded through the dot-com boom and subsequent collapse, are more worried about being underinvested than overexposed right now. “That’s the first time that’s happened since 2021 for us,” the firm’s senior … Read more

Wegovy and Other New Weight Loss Drugs Actually Work—so What’s Next?

Few prescription drugs have entered the public consciousness as abruptly as Ozempic and Wegovy have in recent years. Novo Nordisk’s brand-name medications have become as synonymous with weight loss as Viagra and Cialis are with erectile dysfunction. But while 2023 has made it clear that these and similar drugs really are the future of obesity … Read more

‘Extreme Weight Loss’ Star Brandi Mallory Died of Complications from Obesity

Brandi Mallory died from complications due to obesity — this according to her official autopsy report. TMZ obtained the document from the Fulton County Medical Examiner, citing the “Extreme Weight Loss” star’s weight, an enlarged heart, and some elevated blood indicators suggestive of prediabetes all as factors in her overall health. The paperwork says there … Read more

Roche enters obesity market with Carmot takeover

BRAZIL – 2021/11/26: In this photo illustration a F. HoffmannLa Roche AG logo is seen on a screen and a hand holding a pill. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images) Sopa Images | Lightrocket | Getty Images Swiss pharmaceuticals giant Roche is set to acquire anti obesity drug developer Carmot Therapeutics, becoming … Read more

Pfizer weight loss pill joins list of obesity drug flops

Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.  The drugmaker on Friday said it will stop developing the twice-daily treatment, danuglipron, after obese patients taking the drug … Read more

FDA Approves Eli Lilly’s Zepbound, a Wegovy Competitor

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound. The New M3-Powered iMacs Are … Read more

Obesity medicine euphoria warning: Experts tackle ‘miracle drugs’

Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk on Ozempic’s ability to delay the progression of chronic kidney disease is among the strongest supporting evidence for secondary uses of the drug. However, she considers data … Read more

Obesity pill data boosts Structure Therapeutics shares

Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage trial.  The once-daily drug helped overweight or obese participants reduce up to 10 pounds of weight on average after four weeks of treatment, according to a … Read more